CIK 0001320414
SEM SELECT MEDICAL HOLDINGS CORP
Insider trading from SEC Form 4. Last filing Feb 13, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
19
with a Form 4 at this company
Signals
Open-market buys and sells at SELECT MEDICAL HOLDINGS CORP, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Parvinderjit S. Khanuja director buy | $315k 21,000 shares | +48% | - | |
| 35Weak | David S Chernow CEO sell | $4.0M 225,000 shares | -24% | - | |
| 45Moderate | Robert G. Breighner JR VICE PRESIDENT, COMPLIANCE sell | $100k 4,989 shares | -14% | - | |
| 80Strong | Robert A Ortenzio EXECUTIVE CHAIRMAN sell | $74M 3,804,805 shares | -100% | - | |
| 70Notable | Marilyn B Tavenner director sell | $675k 32,000 shares | -59% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 26, 2024 | Rocco A. Ortenzio Separate Exempt Descendants Trust Affiliate | 3,804,805 2.94% of outstanding | $79M | Nov 26, 2024 | none |
| Nov 26, 2024 | TAVENNER MARILYN B Board Member | 32,000 0.02% of outstanding | $675k | Nov 26, 2024 | none |
Transactions
The last 55 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | William H. Frist director | AGrant or award Common Stock | +1,109 | $16.23 | $18k | 305,172 | Feb 13, 2026 |
| Nov 1, 2025 | John F. Duggan Executive Vice President | FTax withholding Common Stock | -4,865 | $13.83 | $67k | 194,710 | Nov 4, 2025 |
| Nov 1, 2025 | Michael F Malatesta CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -7,357 | $13.83 | $102k | 238,057 | Nov 4, 2025 |
| Oct 28, 2025 | John F. Duggan Executive Vice President | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 199,575 | Oct 30, 2025 |
| Oct 28, 2025 | William H. Frist director | AGrant or award Common Stock | +1,266 | $14.22 | $18k | 304,063 | Oct 30, 2025 |
| Oct 28, 2025 | Christopher Weigl CHIEF ACCOUNTING OFFICER | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 54,254 | Oct 30, 2025 |
| Aug 1, 2025 | Michael E Tarvin EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -19,640 | $12.57 | $247k | 508,120 | Aug 4, 2025 |
| Aug 1, 2025 | John A. Saich EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -21,745 | $12.57 | $273k | 736,412 | Aug 4, 2025 |
| Aug 1, 2025 | Brian R. Rusignuolo Chief Information Officer | FTax withholding Common Stock | -14,680 | $12.57 | $185k | 361,370 | Aug 4, 2025 |
| Aug 1, 2025 | Thomas P Mullin CO-PRESIDENT | FTax withholding Common Stock | -22,045 | $12.57 | $277k | 391,709 | Aug 4, 2025 |
| Aug 1, 2025 | Martin F Jackson EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -29,460 | $12.57 | $370k | 1,383,421 | Aug 4, 2025 |
| Aug 1, 2025 | David S Chernow CEO | FTax withholding Common Stock | -49,100 | $12.57 | $617k | 892,830 | Aug 4, 2025 |
| Jul 29, 2025 | John A. Saich EXECUTIVE VICE PRESIDENT | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 758,157 | Jul 31, 2025 |
| Apr 29, 2025 | Russell L Carson director | GGift Common Stock | -500,000 | $0.00 | $0 | 596,000 | Jul 31, 2025 |
| Jul 29, 2025 | Daniel Thomas director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 80,035 | Jul 31, 2025 |
| Jul 29, 2025 | Michael E Tarvin EXECUTIVE VICE PRESIDENT | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 527,760 | Jul 31, 2025 |
| Jul 29, 2025 | Marilyn B Tavenner director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 36,035 | Jul 31, 2025 |
| Jul 29, 2025 | Thomas Scully director, owner | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 103,424 | Jul 31, 2025 |
| Jul 29, 2025 | Brian R. Rusignuolo Chief Information Officer | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 376,050 | Jul 31, 2025 |
| Jul 29, 2025 | Robert A Ortenzio EXECUTIVE CHAIRMAN | AGrant or award Common Stock | +250,000 | $0.00 | $0 | 7,081,788 | Jul 31, 2025 |
| Jul 29, 2025 | Thomas P Mullin CO-PRESIDENT | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 413,754 | Jul 31, 2025 |
| Jul 29, 2025 | Parvinderjit S. Khanuja director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 79,124 | Jul 31, 2025 |
| Jul 29, 2025 | Michael F Malatesta CHIEF FINANCIAL OFFICER | AGrant or award Common Stock | +75,000 | $0.00 | $0 | 245,414 | Jul 31, 2025 |
| Jul 29, 2025 | David S Chernow CEO | AGrant or award Common Stock | +250,000 | $0.00 | $0 | 941,930 | Jul 31, 2025 |
| Jul 29, 2025 | Katherine R Davisson director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 60,035 | Jul 31, 2025 |
| Jul 29, 2025 | James S. Ely III director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 161,674 | Jul 31, 2025 |
| Jul 29, 2025 | William H. Frist director | AGrant or award Common Stock | +1,263 | $14.25 | $18k | 288,762 | Jul 31, 2025 |
| Jul 29, 2025 | Martin F Jackson EXECUTIVE VICE PRESIDENT | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 1,412,881 | Jul 31, 2025 |
| Jul 29, 2025 | William H. Frist director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 302,797 | Jul 31, 2025 |
| Jul 29, 2025 | Russell L Carson director | AGrant or award Common Stock | +14,035 | $0.00 | $0 | 610,035 | Jul 31, 2025 |
| May 5, 2025 | Parvinderjit S. Khanuja director | POpen-market purchase Common Stock | +21,000 | $15.02 | $315k | 65,089 | May 6, 2025 |
| May 4, 2025 | Robert G. Breighner JR VICE PRESIDENT, COMPLIANCE | FTax withholding Common Stock | -1,330 | $14.26 | $19k | 36,026 | May 5, 2025 |
| Apr 30, 2025 | David S Chernow CEO | FTax withholding Common Stock | -22,586 | $18.24 | $412k | 691,930 | May 1, 2025 |
| Apr 30, 2025 | Michael E Tarvin EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -9,034 | $18.24 | $165k | 427,760 | May 1, 2025 |
| Apr 29, 2025 | Robert G. Breighner JR VICE PRESIDENT, COMPLIANCE | AGrant or award Common Stock | +7,000 | $0.00 | $0 | 37,356 | Apr 30, 2025 |
| Apr 29, 2025 | William H. Frist director | AGrant or award Common Stock | +978 | $18.41 | $18k | 287,499 | Apr 30, 2025 |
| Apr 28, 2025 | David S Chernow CEO | SOpen-market sale Common Stock10b5-1 | -225,000 | $18.00 | $4.0M | 714,516 | Apr 29, 2025 |
| Feb 12, 2025 | William H. Frist director | AGrant or award Common Stock | +987 | $18.24 | $18k | 286,521 | Feb 13, 2025 |
| Dec 4, 2024 | Robert G. Breighner JR VICE PRESIDENT, COMPLIANCE | SOpen-market sale Common Stock | -4,989 | $19.95 | $100k | 30,356 | Dec 6, 2024 |
| Nov 26, 2024 | Robert A Ortenzio EXECUTIVE CHAIRMAN | SOpen-market sale Common Stockindirect: By the Rocco A. Ortenzio Separate Exempt Descendants Trust | -3,804,805 | $19.55 | $74M | 0 | Nov 29, 2024 |
| Nov 26, 2024 | Marilyn B Tavenner director | SOpen-market sale Common Stock | -32,000 | $21.09 | $675k | 22,000 | Nov 29, 2024 |
| Nov 5, 2024 | Robert G. Breighner JR VICE PRESIDENT, COMPLIANCE | FTax withholding Common Stock | -2,659 | $37.21 | $99k | 35,345 | Nov 7, 2024 |
| Nov 5, 2024 | David S Chernow PRESIDENT AND CEO | FTax withholding Common Stock | -70,704 | $37.21 | $2.6M | 939,516 | Nov 7, 2024 |
| Nov 5, 2024 | Martin F Jackson EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -42,422 | $37.21 | $1.6M | 1,262,881 | Nov 7, 2024 |
| Nov 5, 2024 | Michael F Malatesta CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -22,070 | $37.21 | $821k | 170,414 | Nov 7, 2024 |
| Nov 5, 2024 | Thomas P Mullin CO-PRESIDENT | FTax withholding Common Stock | -36,742 | $37.21 | $1.4M | 313,754 | Nov 7, 2024 |
| Nov 5, 2024 | Brian R. Rusignuolo Chief Information Officer | FTax withholding Common Stock | -25,690 | $37.21 | $956k | 301,050 | Nov 7, 2024 |
| Nov 5, 2024 | Christopher Weigl CHIEF ACCOUNTING OFFICER | FTax withholding Common Stock | -5,746 | $37.21 | $214k | 34,254 | Nov 7, 2024 |
| Nov 5, 2024 | Michael E Tarvin EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -28,282 | $37.21 | $1.1M | 436,794 | Nov 7, 2024 |
| Nov 5, 2024 | John A. Saich EXECUTIVE VICE PRESIDENT | FTax withholding Common Stock | -36,242 | $37.21 | $1.3M | 658,157 | Nov 7, 2024 |
| Oct 29, 2024 | William H. Frist director | AGrant or award Common Stock | +543 | $33.14 | $18k | 285,534 | Oct 31, 2024 |
| Oct 29, 2024 | Parvinderjit S. Khanuja director | AGrant or award Common Stock | +543 | $33.14 | $18k | 44,089 | Oct 31, 2024 |
| Oct 27, 2024 | Michael F Malatesta CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -8,828 | $31.74 | $280k | 192,484 | Oct 28, 2024 |
| Oct 27, 2024 | Thomas P Mullin CO-PRESIDENT | FTax withholding Common Stock | -11,023 | $31.74 | $350k | 350,496 | Oct 28, 2024 |
| Oct 27, 2024 | Brian R. Rusignuolo Chief Information Officer | FTax withholding Common Stock | -11,010 | $31.74 | $349k | 326,740 | Oct 28, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Robert G. Breighner JRVICE PRESIDENT, COMPLIANCE
- Russell L Carsondirector
- David S ChernowCEO
- Katherine R Davissondirector
- John F. DugganExecutive Vice President
- James S. Ely IIIdirector
- William H. Fristdirector
- Martin F JacksonEXECUTIVE VICE PRESIDENT
- Parvinderjit S. Khanujadirector
- Michael F MalatestaCHIEF FINANCIAL OFFICER
- Thomas P MullinCO-PRESIDENT
- Robert A OrtenzioEXECUTIVE CHAIRMAN
- Brian R. RusignuoloChief Information Officer
- John A. SaichEXECUTIVE VICE PRESIDENT
- Thomas Scullydirector, owner
- Michael E TarvinEXECUTIVE VICE PRESIDENT
- Marilyn B Tavennerdirector
- Daniel Thomasdirector
- Christopher WeiglCHIEF ACCOUNTING OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.